AbbVie Inc Earnings
The next earnings date for AbbVie Inc is July 31, 2026.
They are scheduled to announce earnings before the market opens that day.
Analyst Estimates of AbbVie Inc Earnings
| 07/31/2026 | $3.64 |
What is an Earnings Date
An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.
Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.
Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.
AbbVie Inc Earnings: Historical
| 04/29/2026 | Before Market | $2.65 | -0.75% |
| 02/04/2026 | Before Market | $2.71 | 2.26% |
| 10/31/2025 | Before Market | $1.86 | 4.49% |
| 07/31/2025 | Before Market | $2.97 | 2.06% |
| 04/25/2025 | Before Market | $2.46 | 2.50% |
| 01/31/2025 | Before Market | $2.16 | 1.89% |
| 10/30/2024 | Before Market | $3 | 2.74% |
| 07/25/2024 | Before Market | $2.65 | -0.38% |
| 04/26/2024 | Before Market | $2.31 | 3.59% |
| 02/02/2024 | Before Market | $2.79 | 0.72% |
More About AbbVie Inc
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma; and Emrelis for the treatment of lung cancer. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox Cosmetic for the treatment of glabellar lines, crow's feet, forehead lines, and platysma bands; Juvederm Collection to treat volume loss in the temples, undereye, cheeks, chin, lips and lower face; Vraylar to treat schizophrenia, bipolar disorder, and depressive disorder; Duodopa to treat Parkinson's disease; Ubrelvy to treat migraine; Qulipta for episodic and chronic migraine; and Vyalev for the treatment of motor fluctuations, as well as Botox Therapeutic to treat chronic migraine, overactive bladder, spasticity, cervical dystonia, and other conditions. In addition, the company offers Ozurdex for visual impairment; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; and other eye care products, including Refresh/Optive, Xen, Durysta, and Restasis. Further, it provides Mavyret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; and Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
“AbbVie Inc Earnings” Can Refer to the AbbVie Inc Earnings Date
Some people say “AbbVie Inc earnings” as a shortform way to refer to the earnings date.
For example, someone might say, “I plan to hold my AbbVie Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.
Owning AbbVie Inc Stock on the Earnings Date
If you own AbbVie Inc stock (ABBV) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.
A company’s earnings typically have a big impact on its stock price, which explains why the stock price for AbbVie Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.
There is often a big audience of investors involved with trading AbbVie Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.
These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.
Owning AbbVie Inc Options on the Earnings Date
If you own AbbVie Inc options on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.
In addition, the extrinsic values of AbbVie Inc options that overlap earnings dates are often higher than other days of the year. In other words, the premiums you pay to own AbbVie Inc options are typically higher during that period. In particular, they are frequently higher immediately before earnings and on the day they’re announced.
This makes sense considering that prices are often more volatile on earnings dates for AbbVie Inc. That potential volatility is a key factor that affects the premium cost of owning options.
Once the earnings announcement is done and the anticipated price volatility has gone down, the extrinsic values of AbbVie Inc options often go down. This is sometimes referred to as volatility crush.
Learning More AbbVie Inc Earnings
You can contact us any time if you would like to ask questions about AbbVie Inc earnings or anything else related to the stock market.